首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1521154

生物反應器市場報告按類型（玻璃、不銹鋼、一次性）、用途（實驗室規模生產、中試規模生產、大規模生產）、規模（5L-20L、20L-200L、200L-1500L、1500L以上））、控制類型（手動、自動）和區域2024-2032

Bioreactor Market Report by Type (Glass, Stainless Steel, Single-Use), Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Scale (5L-20L, 20L-200L, 200L-1500L, Above 1500L), Control Type (Manual, Automated), and Region 2024-2032

出版日期: 2024年07月01日 | 出版商:

IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球生物反應器市場規模達72億美元。有效治療藥物的日益普及，以及預防性疫苗需求的不斷成長，主要推動了市場的發展。

生物反應器市場分析：

主要市場促進因素：包括糖尿病和癌症在內的慢性病盛行率不斷上升，特別是在老年族群中，是支撐市場的因素之一。此外，各國不斷成長的生物製藥製造能力也是重要的成長誘導因素。

主要市場趨勢：眾多技術進步，包括開發一次性生物反應器（SUB），以最小的成本和能源需求最佳化微生物操作形成的靈活性、品質和可擴展性，是刺激整個市場的新興趨勢。

競爭格局：全球市場上一些知名的公司包括 2mag AG、bbi-biotech GmbH、Bioengineering AG、Eppendorf SE、Getinge AB、Infors AG、Merck KGaA、Pall Corporation（丹納赫公司）、Sartorius AG、Solaris Biotechnology Srl、和賽默飛世爾科技公司等。

地理趨勢：由於北美地區非常重視研發活動，因此該地區目前在市場上佔有明顯的主導地位。除此之外，政府機構推出的優惠政策支持永續且具成本效益的生產方法，進一步為市場創造了正面成果。

挑戰與機會：產業參與者對一致的產品品質和可擴展性的日益擔憂阻礙了市場的成長。然而，先進監測和控制技術的日益整合以最佳化生物過程和提高可重複性將在預測期內繼續推動全球市場。

生物反應器市場趨勢：

一次性生物反應器的使用

一次性生物反應器（SUB）因其靈活性、成本效益、污染風險降低等優點而受到廣泛歡迎。根據 IMARC 的數據，2023 年全球一次性生物反應器市場規模將達到 34 億美元。展望未來， IMARC Group預計到 2032 年該市場將達到 111 億美元，從而呈現 13.8% 的成長率 (CAGR) 2024- 2032。此外，與傳統的不銹鋼生物反應器不同，SUB 採用一次性袋子，這有助於消除批次之間大量清潔和滅菌的需要。 2023 年 12 月，Cellexus 推出了氣升式拋棄式生物反應器系統，為細胞的快速生長提供最佳的通氣條件。這種溫和攪拌的方法通常適用於微生物發酵和細胞培養。除此之外，主要參與者也正在生產創新的SUB設計，以滿足小規模研究和大規模生產的需求，這推動了生物反應器市場的前景。例如，2024年2月，合約開發和製造組織（CDMO）藥明生物宣佈在愛爾蘭投資約3.25億歐元，建造約54,000公升一次性生物反應器產能的一次性場地。此外，2024 年3 月，Thermo Fisher Scientific(TM) 推出了一系列針對HyPerforma(TM) 一次性生物反應器(SUB) 產品平台的特定應用增強功能，每項增強功能均針對強化補料分批、灌注、及貼壁細胞培養物。同樣，2024 年 3 月，Distek, Inc. 推出了用於哺乳動物細胞生長和重組蛋白生產的一次性生物反應器 (SUB) 系統。此外，知名公司之間的持續合作預計將在未來幾年擴大市場。例如，2024年6月，Aragen Bioscience和Getinge宣布成功驗證後者的一次性生產反應器（SUPR）。為此，此次合作結合了 Getinge 的創新一次性技術和 Aragen 在生物製藥製造方面的專業知識。

自動化的進步

新型控制系統和自動化與生物反應器的廣泛整合，透過實現對 pH、溫度、溶解氧等關鍵參數的精確控制和即時監控，正在徹底改變生物加工。這是一個重要的生長誘導因子。例如，2023 年8 月，Repligen 公司和Sartorius 推出了一種整合式生物反應器系統，該系統包括完全相容的嵌入式XCell ATF 軟體和硬體模組，提供具有整合式製程分析技術(PAT) 的預定義高階控制配方。此外，該系統旨在為使用者提供一種簡化的方法來控制細胞生長並增強灌注過程中的細胞保留，而無需使用單獨的細胞保留控制塔。除此之外，2023年9月，生物技術解決方案創新者之一的Automated Control Concepts (ACC)發布了其尖端的生物反應器控制和資料平台Lab Owl，該平台允許調整多個過程參數和精確監控，從而實現一致且可重複的結果。除此之外，2023年12月，Cultzyme推出了生物反應器智慧操作奈米技術（BION）系統，配備人工智慧、硬體和雲端運算，以控制生物製造過程，更有效率、以最低成本實現一致的結果。此外，對先進控制系統的需求不斷增加，因為它們有助於從實驗室規模無縫擴大到生產規模，這有助於確保多種生物反應器尺寸的一致性能，也增加了生物反應器市場收入。例如，2024 年 4 月，Culture Biosciences 創建了具有先進控制系統和即時監控功能的生物反應器，旨在容納中國倉鼠卵巢 (CHO) 細胞。

永續生物加工的發展

永續性正在成為市場的關鍵考慮因素。知名企業正致力於最大限度地減少能源消耗和廢物產生，這刺激了市場成長。 2023 年 10 月，奈良科學技術研究所和藤田大學的一組研究人員推出了一種混合電腦模擬/細胞內控制器(HISICC)，它將電腦前饋控制與基因改造活細胞無縫整合，為成本降低提供了潛力。除此之外，2023 年11 月，ADM 和Solugen 建立了戰略合作夥伴關係，建造約50 萬平方英尺的生物製造設施，以開發分子以取代現有的基於化石燃料的材料，並擴大其低碳有機酸生產線。此外，生物反應器製造商正在投資生物反應器設計的多項創新，例如更有效率的混合和曝氣系統，這提高了綠色生物加工解決方案的受歡迎程度。例如，勃林格殷格翰提供動物健康領域的生物製程技術業務，並更重視環境永續性。為此，從不斷討論和評估當前實踐到最佳化抗原生物製造的工藝鏈，該公司堅定致力於最大限度地減少其環境足跡。此外，2024 年 3 月，英國研究與創新 (UKRI) 宣布開展 21 項跨部門合作，以推動全國永續生物製造的進步。

The global bioreactor market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.6 Billion by 2032, exhibiting a growth rate (CAGR) of 10.9% during 2024-2032. The increasing adoption of effective treatment drugs, along with the rising need for preventive vaccines, is primarily propelling the market.

Bioreactor Market Analysis:

Major Market Drivers: The rising prevalence of chronic diseases, including diabetes and cancer, particularly among the geriatric population, is one of the factors bolstering the market. Moreover, the growing biopharmaceutical manufacturing capacities across various countries are also acting as significant growth-inducing factors.

Key Market Trends: Numerous technological advancements, including the development of single-use bioreactors (SUBs) for optimizing the flexibility, quality, and scalability of the formation of microorganism operations with minimal cost and energy requirements, are among the emerging trends stimulating the overall market.

Competitive Landscape: Some of the prominent companies in the global market include 2mag AG, bbi-biotech GmbH, Bioengineering AG, Eppendorf SE, Getinge AB, Infors AG, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Solaris Biotechnology Srl, and Thermo Fisher Scientific Inc., among many others.

Geographical Trends: North America currently exhibits a clear dominance in the market, on account of the region's strong emphasis on R&D activities. Apart from this, the launch of favorable policies by government bodies to support sustainable and cost-effective production methods is further creating a positive outcome for the market.

Challenges and Opportunities: The elevating concerns among industry players regarding consistent product quality and scalability are hindering the market growth. However, the increasing integration of advanced monitoring and control technologies to optimize bioprocesses and enhance reproducibility will continue to catalyze the global market over the forecasted period.

Bioreactor Market Trends:

Usage of Single-Use Bioreactors

Single-use bioreactors (SUBs) are gaining extensive popularity, owing to their benefits, such as flexibility, cost-effectiveness, reduced risk of contamination, etc. This, in turn, is stimulating the market. According to the IMARC, the global single-use bioreactors market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2032, thereby exhibiting a growth rate (CAGR) of 13.8% during 2024-2032. Moreover, unlike traditional stainless-steel bioreactors, SUBs adopt disposable bags, which aids in eliminating the need for extensive cleaning and sterilization between batches. In December 2023, Cellexus introduced airlift single-use disposable bioreactor systems that offer optimal aeration for the rapid growth of cells. This method of gentle agitation is usually suitable for microbial fermentation and cell culture. Besides this, key players are also producing innovative SUB designs, catering to both small-scale research and large-scale production needs, which is fueling the bioreactor market outlook. For instance, in February 2024, the contract development and manufacturing organization (CDMO), WuXi Biologics, announced the construction of a single-use site with approximately 54,000 L of disposable bioreactor capacity via an investment of roughly €325 Million in Ireland. Additionally, in March 2024, Thermo Fisher Scientific(TM) launched a series of application-specific enhancements to the HyPerforma(TM) single-use bioreactor (SUB) product platform, each tailored to the unique requirements of intensified fed-batch, perfusion, and adherent cell cultures. Similarly, in March 2024, Distek, Inc. unveiled a single-use bioreactor (SUB) system for mammalian cell growth and recombinant protein production. Furthermore, continuous collaborations among prominent companies are projected to augment the market in the coming years. For example, in June 2024, Aragen Bioscience and Getinge announced the successful validation of the latter's single-use production reactors (SUPR). In line with this, the collaboration combined Getinge's innovative single-use technology and Aragen's expertise in biopharmaceutical manufacturing.

Advancements in Automation

The widespread integration of novel control systems and automation with bioreactors is revolutionizing bioprocessing by enabling precise control over critical parameters, such as pH, temperature, dissolved oxygen, etc., and real-time monitoring. This is acting as a significant growth-inducing factor. For instance, in August 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system that comprises a fully compatible embedded XCell ATF software and hardware module offering predefined advanced control recipes with integrated process analytical technology (PAT). Additionally, the system aims to provide users with a streamlined way to control cell growth and enhance cell retention in perfusion processes without utilizing a separate cell retention control tower. Besides this, in September 2023, Automated Control Concepts (ACC), one of the innovators in biotechnology solutions, released its cutting-edge bioreactor control and data platform, Lab Owl, that allows for adjustment of multiple process parameters and precise monitoring, resulting in consistent and reproducible outcomes. Apart from this, in December 2023, Cultzyme launched a bioreactor intelligent operative nanotechnology (BION) system equipped with AI, hardware, and cloud computing to control the biomanufacturing process and achieve consistent outcomes more efficiently and at minimal costs. Furthermore, the escalating demand for advanced control systems, as they facilitate seamless scale-up from laboratory to production scale, which aids in ensuring consistent performance across numerous bioreactor sizes, is also increasing the bioreactor market revenue. For instance, in April 2024, Culture Biosciences created bioreactors with advanced control systems and real-time monitoring capabilities designed to accommodate Chinese Hamster Ovary (CHO) cells.

Development of Sustainable Bioprocessing

Sustainability is becoming a critical consideration in the market. Prominent players are focusing on minimizing energy consumption and waste generation, which is stimulating the market growth. In October 2023, a team of researchers at the Nara Institute of Science and Technology and Fujita University introduced a hybrid in silico/in-cell controller (HISICC) that seamlessly integrates computerized feedforward control with genetically modified living cells, offering the potential for cost-effective and eco-friendly chemical and fuel production. Besides this, in November 2023, ADM and Solugen formed a strategic partnership to build an approximately 500,000-ft2 biomanufacturing facility to develop molecules to replace existing fossil fuel-based materials and scale its line of lower-carbon organic acids. Moreover, bioreactor manufacturers are investing in several innovations in bioreactor design, such as more efficient mixing and aeration systems, which is elevating the popularity of greener bioprocessing solutions. For example, Boehringer Ingelheim offers bioprocess technology operations in animal health with an improved focus on environmental sustainability. In line with this, from continuously discussing and evaluating current practices to optimizing process chains for antigenic biological manufacturing, the company is strongly committed to minimizing its environmental footprint. Additionally, in March 2024, the UK Research and Innovation (UKRI) announced 21 cross-sector collaborations to drive advancements in sustainable biomanufacturing across the country.

Global Bioreactor Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the bioreactor market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type, usage, scale, and control type.

Breakup by Type:

Glass

Stainless Steel

Single-Use

Among these, single-use currently exhibit a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes glass, stainless steel, and single-use. According to the report, single-use represented the largest market segmentation.

A single-use bioreactor (SUB) is widely utilized, as it is flexible and easy to use and install. Moreover, it minimizes the risk of cross-contamination, reduces labor costs, eliminates the cleaning process and validation issues, etc., thereby propelling the segment's growth. For example, in March 2024, ABEC introduced a single-use bioreactor system for cell culture production. Additionally, in February 2024, MilliporeSigma developed three Mobius(R) products that deliver improved efficiency and ease of use for biopharmaceutical manufacturing workflows. In line with this, variants include a 2000-liter mixing system for difficult-to-mix biopharm ingredients, a single-use bioreactor with an industry-leading design, and a liquid transport system for non-aseptic and aseptic substances.

Breakup by Usage:

Lab-Scale Production

Pilot-Scale Production

Full-Scale Production

Currently, pilot-scale production holds the largest bioreactor market share

The report has provided a detailed breakup and analysis of the market based on the usage. This includes lab-scale production, pilot-scale production, and full-scale production. According to the report, pilot-scale production represented the largest market segmentation.

Pilot-scale production in bioreactors serves as a crucial intermediary step between laboratory research and full-scale manufacturing in the biopharmaceutical industry. This phase allows for the optimization of bioprocesses on a scale that closely mimics commercial production, providing valuable insights into process performance, scalability, and reproducibility. Pilot-scale bioreactors typically range from 50 to 500 liters in capacity. For instance, in January 2024, San Francisco-based SciFi Foods announced the successful completion of its first commercial bioreactor facility in San Leandro, California. They are used to test and refine production parameters such as cell growth, nutrient consumption, and product yield under conditions that replicate those of large-scale operations. Additionally, pilot-scale production facilitates regulatory compliance by generating data required for process validation and quality assurance. Companies like GE Healthcare and Sartorius offer advanced pilot-scale bioreactor systems equipped with sophisticated monitoring and control technologies, enabling precise control over critical process parameters and ensuring a seamless transition to large-scale manufacturing.

Breakup by Scale:

5L-20L

20L-200L

200L-1500L

Above 1500L

The report has provided a detailed breakup and analysis of the market based on the scale. This includes 5l-20l, 20l-200l, 200l-1500l, and above 1500l.

Bioreactors are designed in various scales to meet the needs of different stages of bioprocessing, from research and development to full-scale commercial production. Small-scale bioreactors, typically ranging from 5L to 20L, are primarily used in laboratory settings for early-stage research, process development, and small-batch production. As per the bioreactor market statistics, they are essential for optimizing cell culture conditions and conducting preliminary studies. Medium-scale bioreactors, with capacities between 20L and 200L, serve as a bridge between laboratory research and pilot-scale production, allowing for the refinement of bioprocesses and scaling up experiments to a semi-industrial level. Bioreactors in the 200L to 1500L range are used for pilot-scale production, providing a realistic simulation of commercial-scale operations and facilitating the validation of production processes. Finally, bioreactors with capacities above 1500L are employed in full-scale commercial production, capable of producing large volumes of biologics, vaccines, and other biopharmaceutical products. For instance, in March 2024, Syngene International, a global contract research, development, and manufacturing organization (CRDMO), introduced a biologics facility with five 2000L single-use bioreactors in Bangalore, India.

Breakup by Control Type:

Manual

Automated

Currently, automated holds the largest bioreactor market share

The report has provided a detailed breakup and analysis of the market based on the control type. This includes manual and automated. According to the report, automated represented the largest market segmentation.

Automated bioreactors are revolutionizing bioprocessing by integrating advanced control systems that enhance precision, efficiency, and scalability. They allow for real-time monitoring and control of critical parameters, including temperature, pH, dissolved oxygen, etc. The system's automation capabilities minimize human intervention, thereby reducing the risk of contamination and errors while optimizing cell growth and product yield. For example, in May 2024, a team of researchers at Florida International University developed an automated 3D-printed bioreactor to grow bone in the lab. Additionally, biopharmaceutical manufacturers offer versatile and robust solutions to enhance productivity and maintain high standards of quality and compliance. For instance, in September 2023, Automated Control Concepts (ACC), one of the leading innovators in biotechnology solutions, announced the development of its cutting-edge bioreactor control and data platform, Lab Owl, to redefine the landscape of bioprocessing.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America bioreactor market is witnessing robust growth, fueled by the region's strong emphasis on biopharmaceutical research, development, and manufacturing. Additionally, advancements in bioprocessing technologies, such as single-use bioreactors and automation, are enhancing the efficiency and scalability of biomanufacturing processes. The presence of major pharmaceutical and biotechnology companies, coupled with supportive government initiatives and funding, is further propelling the bioreactor market demand. In February 2024, Thermo Fisher Scientific expanded its manufacturing capacity at its Missouri, U.S. site to produce complex biologic treatments for a range of diseases, including cancer, autoimmune conditions, and rare disorders. Furthermore, the North America bioreactor market is poised for continued growth, driven by technological advancements and increasing biopharmaceutical production demands. For instance, in March 2023, Micro Digital Co. signed a formal contract to supply bioreactors to expand its presence in North America.

Competitive Landscape:

The bioreactor market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

2mag AG

bbi-biotech GmbH

Bioengineering AG

Eppendorf SE

Getinge AB

Infors AG

Merck KGaA

Pall Corporation (Danaher Corporation)

Sartorius AG

Solaris Biotechnology Srl

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Bioreactor Market Recent Developments:

June 2024: Aragen Bioscience and Getinge announced the successful validation of the latter's single-use production reactors (SUPR) for large-scale recombinant antibody manufacturing.

May 2024: Multiply Labs, one of the robotics companies developing automated manufacturing systems to produce individualized drugs, and Wilson Wolf collaborated to automate Wilson Wolf's G-Rex(R) bioreactors for cell therapy manufacturing.

May 2024: A team of researchers at Florida International University introduced an automated 3D-printed bioreactor to grow bone in the lab.

Key Questions Answered in This Report

1. What was the size of the global bioreactor market in 2023?
2. What is the expected growth rate of the global bioreactor market during 2024-2032?
3. What are the key factors driving the global bioreactor market?
4. What has been the impact of COVID-19 on the global bioreactor market?
5. What is the breakup of the global bioreactor market based on the type?
6. What is the breakup of the global bioreactor market based on the usage?
7. What is the breakup of the global bioreactor market based on the control type?
8. What are the key regions in the global bioreactor market?
9. Who are the key players/companies in the global bioreactor market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Bioreactor Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Glass
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Stainless Steel
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Single-Use
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Usage

7.1 Lab-Scale Production
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Pilot-Scale Production
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Full-Scale Production
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Scale

8.1 5L-20L
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 20L-200L
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 200L-1500L
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Above 1500L
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Control Type

9.1 Manual
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Automated
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 2mag AG
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 bbi-biotech GmbH
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Bioengineering AG
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Eppendorf SE
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Getinge AB
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Infors AG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Pall Corporation (Danaher Corporation)
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
- 15.3.9 Sartorius AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Solaris Biotechnology Srl
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Bioreactor Market: Major Drivers and Challenges
Figure 2: Global: Bioreactor Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Bioreactor Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Bioreactor Market: Breakup by Type (in %), 2023
Figure 5: Global: Bioreactor Market: Breakup by Usage (in %), 2023
Figure 6: Global: Bioreactor Market: Breakup by Scale (in %), 2023
Figure 7: Global: Bioreactor Market: Breakup by Control Type (in %), 2023
Figure 8: Global: Bioreactor Market: Breakup by Region (in %), 2023
Figure 9: Global: Bioreactor (Glass) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Bioreactor (Glass) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Bioreactor (Stainless Steel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Bioreactor (Stainless Steel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Bioreactor (Single-Use) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Bioreactor (Single-Use) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Bioreactor (Lab-Scale Production) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Bioreactor (Lab-Scale Production) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Bioreactor (Pilot-Scale Production) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Bioreactor (Pilot-Scale Production) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Bioreactor (Full-Scale Production) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Bioreactor (Full-Scale Production) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Bioreactor (5L-20L) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Bioreactor (5L-20L) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Bioreactor (20L-200L) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Bioreactor (20L-200L) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Bioreactor (200L-1500L) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Bioreactor (200L-1500L) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Bioreactor (Above 1500L) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Bioreactor (Above 1500L) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Bioreactor (Manual) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Bioreactor (Manual) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Bioreactor (Automated) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Bioreactor (Automated) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North America: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: North America: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: United States: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: United States: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Canada: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Canada: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia-Pacific: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia-Pacific: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: China: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: China: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Japan: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Japan: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: India: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: India: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: South Korea: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: South Korea: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Australia: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Australia: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Indonesia: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Indonesia: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Others: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Others: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Europe: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Germany: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Germany: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: France: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: France: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: United Kingdom: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: United Kingdom: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Italy: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Italy: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Spain: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Spain: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Russia: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Russia: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Latin America: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Latin America: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Brazil: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Brazil: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Mexico: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Mexico: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Middle East and Africa: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Middle East and Africa: Bioreactor Market: Breakup by Country (in %), 2023
Figure 81: Middle East and Africa: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Bioreactor Industry: SWOT Analysis
Figure 83: Global: Bioreactor Industry: Value Chain Analysis
Figure 84: Global: Bioreactor Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Bioreactor Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Bioreactor Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Bioreactor Market Forecast: Breakup by Usage (in Million US$), 2024-2032
Table 4: Global: Bioreactor Market Forecast: Breakup by Scale (in Million US$), 2024-2032
Table 5: Global: Bioreactor Market Forecast: Breakup by Control Type (in Million US$), 2024-2032
Table 6: Global: Bioreactor Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Bioreactor Market: Competitive Structure
Table 8: Global: Bioreactor Market: Key Players

02-2729-4219

+886-2-2729-4219